Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

psychotherapy

  • Home
  •  
  • psychotherapy



  • Most Read
  • Latest Comments
  • Tripping on psychedelics funded by your health insurance – it’s now a thing
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Tripping on psychedelics funded by your health insurance – it’s now a thing
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Tripping on psychedelics funded by your health insurance – it’s now a thing
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Tripping on psychedelics funded by your health insurance – it’s now a thing
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Tripping on psychedelics funded by your health insurance – it’s now a thing
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Little Green Pharma rejoices at US recommendation to reclassify weed as less dangerous
    Little Green Pharma rejoices at US recommendation to reclassify weed as less dangerous
    • News

  • Little Green Pharma to target growing medicinal cannabis market thanks to legal changes
    Little Green Pharma to target growing medicinal cannabis market thanks to legal changes
    • News

  • Little Green Pharma has big news: a new CEO and 37% revenue growth
    Little Green Pharma has big news: a new CEO and 37% revenue growth
    • News

  • Tripping on psychedelics funded by your health insurance – it’s now a thing
    Tripping on psychedelics funded by your health insurance - it’s now a thing
    • News

  • Treating mental health; TGA approves MDMA and Psilocybin as a medicine
    Treating mental health; TGA approves MDMA and Psilocybin as a medicine
    • News

  • Tripping on psychedelics funded by your health insurance – it’s now a thing
    • News

    Tripping on psychedelics funded by your health insurance – it’s now a thing

    The company at the forefront of the cannabis sector has also ventured into the psychedelic therapy treatment industry, demonstrating a commitment to offer alternative treatments to Little Green Pharma (ASX: LGP) and its subsidiary Reset Mind Sciences, who announced a fresh alliance with Health Insurance Fund Australia (HIF). Joining forces to tackle mental health, the

    Read More
    Public
  • Incannex to launch world-first Magic Mushroom trials to treat anxiety
    • News

    Incannex to launch world-first Magic Mushroom trials to treat anxiety

    Throughout the 1950s, psychotherapy was a form of treatment for mental disorders from limited research but with the world having undertaken medical breakthroughs since, pharmaceuticals company Incannex Healthcare (ASX: IHL) is re-visiting the use of psilocybin as a treatment for anxiety through clinical trials in partnership with Monash University. Psilocybin is better known as magic

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.